CN Patent

CN111991404B — 防治真菌感染的复合维生素d及其应用

Assigned to Southwest Medical University · Expires 2021-08-13 · 5y expired

What this patent protects

本发明公开了一种防治真菌感染的复合维生素D，包括功效成分维生素D2和维生素D3，维生素D2和维生素D3的质量比为1～3:1～5。还公开了该复合维生素D在制备防治真菌感染的药物中的应用。本发明的复合维生素D具有防治曲霉属真菌、新生隐球菌等感染的作用。除此之外，该复合物细胞毒性低，可作为临床抗真菌感染治疗的候选药物。

USPTO Abstract

本发明公开了一种防治真菌感染的复合维生素D，包括功效成分维生素D2和维生素D3，维生素D2和维生素D3的质量比为1～3:1～5。还公开了该复合维生素D在制备防治真菌感染的药物中的应用。本发明的复合维生素D具有防治曲霉属真菌、新生隐球菌等感染的作用。除此之外，该复合物细胞毒性低，可作为临床抗真菌感染治疗的候选药物。

Drugs covered by this patent

Patent Metadata

Patent number
CN111991404B
Jurisdiction
CN
Classification
—
Expires
2021-08-13
Drug substance claim
No
Drug product claim
No
Assignee
Southwest Medical University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.